The Most Expensive Health Decision You Will Ever Make Is Waiting.

A direct conversation about windows, trajectories, and what 15 years at the bedside has taught me about the cost of delay.

I want to have a direct conversation — the kind I have learned to have after 15 years of working with patients who arrived at serious health crossroads. Some arrived early enough. Some did not. The difference between those two groups was rarely about access, resources, or even knowledge. It was almost always about timing.

CKM syndrome progresses in stages. In its earliest phase — which can last years — there are no symptoms, the annual physical appears unremarkable, and the window for intervention is wide open. The cost of acting here is low. The return is high. In its middle phase, subclinical damage is accumulating in the microvasculature of the kidneys and heart. Reversal is still achievable but requires more. In its later phases, the options narrow significantly and the personal cost — dialysis, cardiac events, forced career transitions — becomes severe and permanent.

"Every executive I have ever worked with who waited too long said the same thing afterward: 'I knew something wasn't right. I just kept thinking I'd get to it.' The window does not announce its closing. It simply closes."

You are reading this in a window. The question is not whether you have time to deal with this. The question is whether you will use the time you have. The CKM Risk Assessment takes four minutes. What it reveals could reframe the next 20 years.

TAKE THE CKM ASSESSMENT →